Finance

Lists
SHC:NASDAQ
Sotera Health Co
$16.61
+1.90%
(+0.31) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SHC...
Open
$16.39
High
$16.65
Low
$16.15
Mkt. cap
4.74B
Avg. vol.
2.43M
Volume
2.65M
P/E ratio
27.61
52-wk high
$19.84
52-wk low
$13.09
EPS
$0.60
Beta
1.94
Shares outstanding
285.63M
No. of employees
3K
Open
$16.39
High
$16.65
Low
$16.15
Mkt. cap
4.74B
Avg. vol.
2.43M
Volume
2.65M
P/E ratio
27.61
52-wk high
$19.84
52-wk low
$13.09
EPS
$0.60
Beta
1.94
Shares outstanding
285.63M
No. of employees
3K
News stories
From web sources and news partners
About Sotera Health Co
CEO-
Employees3K
Founded2015
HeadquartersBroadview Heights, Ohio, United States
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to SHC in the past 3 months
Buy
Buy
5
Hold
0
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SHC in the last 3 months.
Highest
Current $16.61
$25.00 (+50.51%)
Average
$21.67 (+30.46%)
Lowest
$15.00 (-9.69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Dodge
BMO Capital
Buy
Reiterated
$22.00
+32.5%
11/03/2026
Ryan Halsted
RBC Capital
Buy
Reiterated
$24.00
+44.5%
11/03/2026
Casey Woodring
J.P. Morgan
Sell
Maintained
$15.00
-9.7%
11/04/2026
Luke Sergott
Barclays
Buy
Maintained
$20.00
+20.4%
11/04/2026
Jason Bednar
Piper Sandler
Buy
Maintained
$25.00
+50.5%
10/19/2026
Evie Koslosky
Goldman Sachs
Buy
Maintained
$24.00
+44.5%
09/20/2026
Patrick B Donnelly
Citi
Buy
Maintained
$25.00
+50.5%
08/07/2026
‏Brendan Digan‏
Citi
Buy
Maintained
$25.00
+50.5%
08/07/2026
Max Smock
William Blair
Buy
Reiterated
-
-
05/05/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
$0.29 / $0.27
+7.95%beat
Revenue / Est. (USD)
324.89M / 319.88M
+1.56%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
303.44M
280.04M
321.38M
324.89M
Cost of goods sold
137.52M
132.98M
143.41M
144.10M
Cost of revenue
137.52M
132.98M
143.41M
144.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.42M
56.50M
52.97M
48.38M
Operating expense
57.44M
59.53M
55.98M
51.38M
Total operating expenses
194.96M
192.50M
199.39M
195.48M
Operating income
108.48M
87.54M
121.98M
129.40M
Other non operating income
7.63M
-899.00K
1.01M
-989.00K
EBT including unusual items
70.50M
42.61M
78.05M
83.73M
EBT excluding unusual items
79.50M
52.47M
92.34M
95.39M
Income tax expense
35.65M
16.02M
24.41M
25.34M
Effective tax rate
50.57%
37.60%
31.27%
30.26%
Other operating expenses
-
-
-
-
Net income
34.85M
26.59M
53.64M
58.39M
Net profit margin
11.48%
9.49%
16.69%
17.97%
Earnings per share
0.26
0.18
0.26
0.29
Interest and investment income
-
-
-
-
Interest expense
-35.05M
-34.74M
-34.40M
-34.12M
Net interest expenses
-35.05M
-34.74M
-34.40M
-34.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
141.59M
119.03M
156.01M
162.55M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps